NCT03329950 · Interventional trial
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Overall registry status Completed
Phase 1
Conditions Bladder Urothelial Carcinoma, Breast Cancer, Cholangiocarcinoma, Colorectal Cancer, Diffuse Large B-cell Lymphoma (DLBCL), Esophageal Cancer, Fallopian Tube Cancer, Follicular Lymphoma, Gastric Cancer, Head and Neck Cancer, Hepatic Cancer, Indolent B-cell Lymphomas, Lymphoplasmacytic Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Melanoma, Mucosa Associated Lymphoid Tissue, Non-Hodgkin Lymphoma, Non-small Cell Lung Cancer, Other Solid Tumors, Ovarian Cancer, Pancreatic Adenocarcinoma, Primary Peritoneal Cancer, Renal Cell Carcinoma, Small Lymphocytic Leukemia, Waldenstrom's Disease
Delaware Valley sites
- Abramson Cancer Center at the University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory